PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Cosentyx gains EU approval for new label extension

Novartis’ interleukin (IL)-17A inhibitor Cosentyx has gained an EU label update to include data for axial manifestations of psoriatic arthritis (PsA). In a statement...
Continue Reading →
News

Cancer Research UK teams up with Teon on new cancer drug

Cancer Research UK (CRUK) has signed a collaboration agreement with Teon Therapeutics to advance early clinical development of the latter’s new cancer drug. The focu...
Continue Reading →
News

New consultancy specialising in healthcare innovation launches

Today sees the launch of Newmarket Strategy, a strategic and technical advisory business specialising in healthcare and life sciences. This new venture brings togeth...
Continue Reading →
News

PHE data shows vaccines reduce severe COVID-19 in older adults

Public Health England (PHE) has submitted a pre-print of a real-world study, with data showing that both the Pfizer and Oxford/AstraZeneca vaccin...
Continue Reading →
News

Abbott researchers find rare group of people with controlled HIV who could be a key to unlocking cure

Abbott (NYSE: ABT) announced today that a team of scientists has found an unusually high number of people in the Democratic Republic of Congo (DRC) who test positive...
Continue Reading →
News

Nanoparticle-delivered COVID-19 vaccine candidate shows promise in preclinical studies

Researchers from Cleveland Clinic's Global Center for Pathogen Research & Human Health have developed a promising new COVID-19 vaccine candidate that utilizes na...
Continue Reading →
News

MHRA approves Seagen’s Tukysa for HER2-positive breast cancer

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Seagen’s Tukysa in combination with trastuzumab and capecitabine for the treatment o...
Continue Reading →
News

UK sees a 20% growth in the number of advanced therapy trials, report finds

The UK has had a 20% growth in the number of advanced therapy medicinal product (ATMP) clinical trials, according to a new report from the Cell and Gene Therapy Cata...
Continue Reading →
News

Amgen looks to expand access to Otezla in the US

Amgen has submitted a supplemental new drug application (sNDA) seeking expanded approval for Otezla in adults with mild-to-moderate plaque psoriasis who are candidat...
Continue Reading →
News

AstraZeneca withdraws Imfinzi indication in US for advanced bladder cancer

AstraZeneca has announced the voluntary withdrawal of the Imfinzi (durvalumab) indication in the US for previously treated adult patients with locally adva...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026